Sintx Technologies Inc (SINT)

$2.47 -0.04 (-1.59%)
Market Cap 10.35M
Revenue (ttm) 1.02M
Net Income (ttm) -10.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,015.69%
Debt to Equity Ratio 0.00
Volume 19,500
Avg Vol 31,542
Day's Range N/A - N/A
Shares Out 4.12M
Stochastic %K 0%
Beta 0.66
Analysts Sell
Price Target $11.00

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (P...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 839 3500
Address:
1885 West 2100 South, Salt Lake City, United States
SnoopyDog
SnoopyDog Apr. 25 at 2:27 PM
$SINT only strawmen in place
0 · Reply
SnoopyDog
SnoopyDog Apr. 24 at 6:42 PM
$SINT also Boston, what is your opinion on outflowing money / selling shares for almost two weeks now daily. The market prepares for SINT running out of cash. And management? Quiet as usual
1 · Reply
FastBull
FastBull Apr. 24 at 5:17 PM
$SINT trash yesterday, trash today and trash tomorrow
0 · Reply
SnoopyDog
SnoopyDog Apr. 23 at 7:49 PM
$SINT you are asking the same questions after Sintx/ Amedica doing the same things for ten years
0 · Reply
Boston7452
Boston7452 Apr. 23 at 6:29 PM
$SINT Why havent we heard anything in 6 months on this? UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market https://www.globenewswire.com/news-release/2025/10/16/3167780/30038/en/update-sintx-strengthens-infection-prevention-portfolio-with-newly-allowed-u-s-patent-covering-30-billion-antipathogenic-addressable-market.html
0 · Reply
SnoopyDog
SnoopyDog Apr. 23 at 6:06 PM
$SINT seems they have nothing in place to support share price. Or again intended
1 · Reply
Boston7452
Boston7452 Apr. 23 at 5:56 PM
$SINT Awarded 1/13/2026 "Described herein is an antiviral face mask and methods of use thereof to inactivate a virus in contact with the face mask. The face mask may include a fibrous material with silicon nitride powder impregnated therein and a layer surrounding the fibrous material. In some embodiments, silicon nitride is present in the fibrous material at a concentration of about 1 wt. % to about 15 wt. %." https://patents.google.com/patent/US12520890B2/en
1 · Reply
Boston7452
Boston7452 Apr. 22 at 6:38 PM
$SINT has solutions for the next pandemic if only they would attempt to bring the products to market. Masks and air filtration being the two main products. Air filtration could be significant for hospitals helping to counter the growing fungal spread in them.
1 · Reply
Boston7452
Boston7452 Apr. 22 at 6:16 PM
$SINT This ‘minor’ bird flu strain has potential to spark human pandemic Experiments suggests H9N2 has adapted to human cells, but cases of person-to-person transmission haven’t been reported yet.
2 · Reply
Boston7452
Boston7452 Apr. 22 at 6:00 PM
$SINT Where's PPE because human spreading is close... "3 more H9N2 avian flu cases confirmed in China" "Italy tracks first European human H9N2 avian flu case "
1 · Reply
Latest News on SINT
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

Mar 23, 2026, 9:15 AM EDT - 4 weeks ago

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Mar 19, 2026, 7:30 AM EDT - 5 weeks ago

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Feb 18, 2026, 8:30 AM EST - 2 months ago

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

Jan 29, 2026, 9:00 AM EST - 3 months ago

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Dec 1, 2025, 8:30 AM EST - 5 months ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

Nov 3, 2025, 8:00 AM EST - 6 months ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Oct 20, 2025, 7:00 AM EDT - 6 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

Oct 14, 2025, 7:00 AM EDT - 6 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

Sep 8, 2025, 7:54 AM EDT - 8 months ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Sep 8, 2025, 7:00 AM EDT - 8 months ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Aug 15, 2025, 7:00 AM EDT - 9 months ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Aug 4, 2025, 7:00 AM EDT - 9 months ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

Jun 24, 2025, 8:30 AM EDT - 10 months ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 22, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025, 7:05 AM EDT - 1 year ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 26, 2025, 8:00 AM EST - 1 year ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 20, 2025, 6:15 AM EST - 1 year ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Feb 19, 2025, 6:00 AM EST - 1 year ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

SINTX Technologies Announces Stock Repurchase Program

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Sep 9, 2024, 8:00 AM EDT - 1 year ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies to Explore Strategic Opportunities

Jun 18, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies to Explore Strategic Opportunities

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 12, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

Jun 6, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

May 23, 2024, 9:00 AM EDT - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 29, 2024, 9:14 AM EDT - 2 years ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Apr 3, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 2 years ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

Feb 23, 2024, 7:50 AM EST - 2 years ago

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

GRI

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

Nov 3, 2023, 8:28 AM EDT - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT HSCS

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Aug 17, 2023, 9:00 AM EDT - 2 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 10, 2023, 1:52 PM EST - 3 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 3 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Jan 19, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

Jan 6, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

SnoopyDog
SnoopyDog Apr. 25 at 2:27 PM
$SINT only strawmen in place
0 · Reply
SnoopyDog
SnoopyDog Apr. 24 at 6:42 PM
$SINT also Boston, what is your opinion on outflowing money / selling shares for almost two weeks now daily. The market prepares for SINT running out of cash. And management? Quiet as usual
1 · Reply
FastBull
FastBull Apr. 24 at 5:17 PM
$SINT trash yesterday, trash today and trash tomorrow
0 · Reply
SnoopyDog
SnoopyDog Apr. 23 at 7:49 PM
$SINT you are asking the same questions after Sintx/ Amedica doing the same things for ten years
0 · Reply
Boston7452
Boston7452 Apr. 23 at 6:29 PM
$SINT Why havent we heard anything in 6 months on this? UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market https://www.globenewswire.com/news-release/2025/10/16/3167780/30038/en/update-sintx-strengthens-infection-prevention-portfolio-with-newly-allowed-u-s-patent-covering-30-billion-antipathogenic-addressable-market.html
0 · Reply
SnoopyDog
SnoopyDog Apr. 23 at 6:06 PM
$SINT seems they have nothing in place to support share price. Or again intended
1 · Reply
Boston7452
Boston7452 Apr. 23 at 5:56 PM
$SINT Awarded 1/13/2026 "Described herein is an antiviral face mask and methods of use thereof to inactivate a virus in contact with the face mask. The face mask may include a fibrous material with silicon nitride powder impregnated therein and a layer surrounding the fibrous material. In some embodiments, silicon nitride is present in the fibrous material at a concentration of about 1 wt. % to about 15 wt. %." https://patents.google.com/patent/US12520890B2/en
1 · Reply
Boston7452
Boston7452 Apr. 22 at 6:38 PM
$SINT has solutions for the next pandemic if only they would attempt to bring the products to market. Masks and air filtration being the two main products. Air filtration could be significant for hospitals helping to counter the growing fungal spread in them.
1 · Reply
Boston7452
Boston7452 Apr. 22 at 6:16 PM
$SINT This ‘minor’ bird flu strain has potential to spark human pandemic Experiments suggests H9N2 has adapted to human cells, but cases of person-to-person transmission haven’t been reported yet.
2 · Reply
Boston7452
Boston7452 Apr. 22 at 6:00 PM
$SINT Where's PPE because human spreading is close... "3 more H9N2 avian flu cases confirmed in China" "Italy tracks first European human H9N2 avian flu case "
1 · Reply
JordiWild
JordiWild Apr. 21 at 11:44 PM
$SINT Recent insider purchases, something is happening?
0 · Reply
JordiWild
JordiWild Apr. 21 at 11:44 PM
$SINT FDA + real-world usage
0 · Reply
SnoopyDog
SnoopyDog Apr. 21 at 6:47 PM
$SINT will we get a classic amedica massacre?
1 · Reply
Boston7452
Boston7452 Apr. 17 at 10:34 PM
$SINT they need to announce something significant to trigger warrant conversion at 4.89. What was it, about $8M raise?
1 · Reply
SnoopyDog
SnoopyDog Apr. 17 at 9:01 PM
$SINT Cash until may?
0 · Reply
Boston7452
Boston7452 Apr. 16 at 7:16 PM
$SINT More likely wash trading walking the price down.
0 · Reply
SnoopyDog
SnoopyDog Apr. 16 at 6:53 PM
$SINT it isnt. Folks unloading. They are running out of cash and market smells it
1 · Reply
Boston7452
Boston7452 Apr. 16 at 1:09 AM
$SINT so hard to buy shares off this one. No one’s really selling.
0 · Reply
amda_sintx
amda_sintx Apr. 15 at 4:51 PM
$SINT whats up folks! Anything good happening here yet, or not, for investors?
1 · Reply
Love_To_Learn
Love_To_Learn Apr. 15 at 11:51 AM
$CLRB $SINT making changes to both u
0 · Reply
Boston7452
Boston7452 Apr. 14 at 3:08 PM
$SINT no buyout yet. Sintx is sitting on billion dollar tech between ortho applications and antipathogenic. Those price targets are nowhere near correct. Need partnership announcement to send this into hundreds of millions.
1 · Reply
2TrustHim
2TrustHim Apr. 14 at 3:07 PM
$HOTH $HURA $SINT All May Run Soon!!!
0 · Reply